Risk factors and characteristics of ocular complications, and efficacy of autologous serum tears after haematopoietic progenitor cell transplantation

Bone Marrow Transplantation

Volumn 38, Issue 3, 2006, Pages 223-227

  Leite, S C ^a   de Castro, R S ^a   Alves, M ^a   Cunha, D A ^a   Correa, M E P ^a   da Silveira, L A ^a   Vigorito, A C ^a   de Souza, C A ^a   Rocha, E M ^a,b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EYE DROPS;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DRY EYE; FEMALE; HUMAN; INFUSION; LACRIMAL FLUID; MAJOR CLINICAL STUDY; MALE; MICROBIAL CONTAMINATION; MICROBIOLOGICAL EXAMINATION; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SCHIRMER TEST; SCHOOL CHILD; SERUM; TEAR FILM; XEROSTOMIA;

ADOLESCENT; ADULT; AGE FACTORS; CHILD; DRY EYE SYNDROMES; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; RISK FACTORS; SERUM;

EID: 33746319881     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705426     Document Type: Article

References (30)

1. Slavin RE, Santos GW. The graft-versus-host reaction in a man after bone marrow transplantation: Pathology, pathogenesis, clinical features and implication. Clin Immunol Immunopathol 1973; 1: 472-498.
2. Gratwohl AA, Moutsopoulos HM, Chused TM, Akizuki M, Wolf RO, Sweet JB et al. Sjögren-type syndrome after allogeneic bone-marrow transplantation. Ann Intern Med 1977; 87: 703-706.
3. Franklin RM, Kenyon KR, Tutschka PJ, Saral R, Green WR, Santos GR. Ocular manifestations of graft-vs-host disease. Ophthalmol 1983; 90: 4-13.
4. Sullivan KM. Graft-versus-host disease. In: Forman SJ, Blurne KG, Thomas ED (eds). Bone Marrow Transplantation. Blackwell Scientific Publications: Boston, 1994, pp 339-362.
5. Bradfield YS, Kushner BJ, Gangnon RE. Ocular complications after organ and bone marrow transplantation in children. J AAPOS 2005; 9: 426-432.
6. Calissendorff B, el-Azazi M, Lonnqvist B. Dry eye syndrome in long-term follow-up of bone marrow transplanted patients. Bone Marrow Transplant 1989; 4: 675-678.
7. Ogawa Y, Okamoto S, Wakui M, Watanabe R, Yamada M, Yoshino M et al. Dry eye after haematopoietic stem cell transplantation. Br J Ophthalmol 1999; 83: 1125-1130.
8. Rocha EM, Wickham LA, Huang Z, Toda I, Gao J, da Silveira LA et al. Presence and testosterone influence on the levels of anti- and pro-inflammatory cytokines in lacrimal tissues of a mouse model of Sjögren's syndrome. Adv Exp Med Biol 1998; 438: 485-491.
9. Rocha EM, Cunha DA, Carneiro EM, Boschero AC, Saad MJ, Velloso LA. Identification of insulin in the tear film and insulin receptor and IGF-1 receptor on the human ocular surface. Invest Ophthalmol Vis Sci 2002; 43: 963-967.
10. Cunha DA, Carneiro EM, Alves MD, Jorge AG, Sousa SM, Boschero AC et al. Insulin secretion by rat lacrimal glands: Effects of systemic and local variables. Am J Physiol Endocrinol Metab 2005; 289: E768-E775.
11. Ogawa. Y, Yamazaki K, Kuwana M, Mashima Y, Nakamura Y, Ishida S et al. A significant role of stromal fibroblasts in rapidly progressive dry eye in patients with chronic GVHD. Invest Ophthalmol Vis Sci 2001; 42: 111-119.
12. Stem Cell Trialists' Collaborative Group. Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of haematologic malignancies: An individual patient data meta-analysis of nine randomized trials. J Clin Oncol 2005; 23: 5074-5087.
13. Vigorito AC, Marques Junior JF, Aranha FJ, Oliveira GB, Miranda EC, De Souza CA. A randomized, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of hematologic malignancies: An update. Haematologica 2001; 86: 665-666.
14. Vigorito AC, Azevedo WM, Marques JFC, Azevedo AM, Eid KAB, Aranha FJP et al. A randomized, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of hematologic malignancies. Bone Marrow Transplant 1998; 22: 1145-1151.
15. Aranha FJ, Vigorito AC, De Sousa CA, Oliveira GB, Zulli R, Lorand-Metze I. The influence of the graft monocytes in the outcome of allogeneic bone marrow transplantation. Haematologica 2002; 87: 219-220.
16. Rocha EM, Paiva CS, Pelegrino FSA, Vigorito AC, Souza CA. GvHD dry eye treated with serum tears. Bone Marrow Transplant 2000; 25: 1101-1104.
17. Tsubota K, Goto E, Fujita H, Ono M, Inoue H, Saito I et al. Treatment of dry eye by autologous serum application in Sjögren's syndrome. Br J Ophthalmol 1999; 83: 390-395.
18. Lemp MA. Report of the national eye institute/industry workshop on clinical trials in dry eyes. CLAO J 1995; 21: 221-232.
19. Sullivan KM, Shulman HM, Storb R, Weiden PL, Witherspoon RP, McDonald GB et al. Chronic graft-versus-host disease in 52 patients: Adverse natural course and successful treatment with combination immunosuppression. Blood 1981; 57: 267-276.
20. Sullivan DA, Wickham LA, Rocha EM, Krenzer KL, Sullivan BD, Steagall R et al. Androgens and dry eye in Sjögren's syndrome. Ann NY Acad Sci 1999; 876: 312-324.
21. Sale GE, Shulman HM, Schubert MM, Sullivan KM, Kopecky KJ, Hackman RC et al. Oral and ophthalmic pathology of graft versus host disease in man: predictive value of the lip biopsy. Hum Pathol 1981; 12: 1022-1030.
22. Jabs DA, Wingard J, Green WR, Farmer ER, Vogelsang G, Saral R. The eye in bone marrow transplantation. III. Conjunctival graft-vs-host disease. Arch Ophthalmol 1989; 107: 1343-1348.
23. Alborghetti MR, Correa ME, Adam RL, Metze K, Coracin FL, de Souza CA et al. Late effects of chronic graft-vs-host disease in minor salivary glands. J Oral Pathol Med 2005; 34: 486-493.
24. Nichols KK, Nichols JJ, Mitchell GL. The lack of association between signs and symptoms in patients with dry eye disease. Cornea 2004; 23: 762-770.
25. Lucca JA, Nunez JN, Farris RL. A comparison of diagnostic tests for keratoconjunctivitis sicca: Lactoplate, Schirmer, and tear osmolarity. CLAO J 1990; 16: 109-112.
26. Kojima T, Ishida R, Dogru M, Goto E, Matsumoto Y, Kaido M et al. The effect of autologous serum eyedrops in the treatment of severe dry eye disease: A prospective randomized case-control study. Am J Ophthalmol 2005; 139: 242-246.
27. Ogawa Y, Okamoto S, Mori T, Yamada M, Mashima Y, Watanabe R et al. Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease. Bone Marrow Transplant 2003; 31: 579-583.
28. Schein OD, Hbberd PL, Starck T, Baker AS, Kenyon KR. Microbial contamination of in-use ocular medications. Arch Ophthalmol 1992; 110: 82-85.
29. Lagnado R, King AJ, Donald F, Dua HS. A protocol for low contamination risk of autologous serum drops in the management of ocular surface disorders. Br J Ophthalmol 2004; 88: 464-465.
30. Sauer R, Bluthner K, Seitz B. Sterility of non-preserved autologous serum drops for treatment of persistent corneal epithelial defects. Ophthalmologe 2004; 101: 705-709.